Swiss National Bank’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.4M Buy
+77,800
New +$1.56M ﹤0.01% 2022
2025
Q1
Sell
-56,600
Closed -$603K 2451
2024
Q4
$603K Hold
56,600
﹤0.01% 2368
2024
Q3
$719K Buy
+56,600
New +$840K ﹤0.01% 2344
2022
Q2
Sell
-47,900
Closed -$417K 2793
2022
Q1
$417K Buy
47,900
+4,000
+9% +$31.2K ﹤0.01% 2627
2021
Q4
$417K Hold
43,900
﹤0.01% 2691
2021
Q3
$738K Hold
43,900
﹤0.01% 2509
2021
Q2
$670K Buy
43,900
+1,400
+3% +$25.3K ﹤0.01% 2591
2021
Q1
$828K Hold
42,500
﹤0.01% 2386
2020
Q4
$766K Hold
42,500
﹤0.01% 2389
2020
Q3
$820K Buy
42,500
+2,700
+7% +$61.1K ﹤0.01% 2190
2020
Q2
$1.04M Buy
39,800
+5,300
+15% +$130K ﹤0.01% 2077
2020
Q1
$615K Buy
34,500
+500
+1% +$13.5K ﹤0.01% 2088
2019
Q4
$1.14M Buy
34,000
+400
+1% +$10.9K ﹤0.01% 2069
2019
Q3
$801K Buy
33,600
+1,400
+4% +$45.8K ﹤0.01% 2169
2019
Q2
$1.16M Hold
32,200
﹤0.01% 2034
2019
Q1
$1.19M Buy
32,200
+14,000
+77% +$587K ﹤0.01% 1980
2018
Q4
$784K Buy
18,200
+1,000
+6% +$45K ﹤0.01% 2135
2018
Q3
$812K Hold
17,200
﹤0.01% 2257
2018
Q2
$856K Buy
+17,200
New +$1M ﹤0.01% 2255

Other funds holding URGN